Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant pulmonary tuberculosis
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine
Reference14 articles.
1. Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa — Third Investigation: The effect of an initial streptomycin supplement;East African/British Medical Research Council Third Thiacetazone Investigation;Tubercle,1966
2. Isoniazid with thiacetazone in the treatment of pulmonary tuberculosis in East Africa — Fifth investigation;East African/British Medical Research Council Fifth Thiacetazone Investigation;Tubercle,1970
3. Tuberculosis in Kenya: Follow-up of the second (1974) national sampling survey and a comparison with the follow-up data from the first (1964) national sampling survey;Second East African/British Medical Research Council Kenya Tuberculosis Survey Follow-up;Tubercle,1979
4. The modern management and therapy of pulmonary tuberculosis;Fox,1977
5. Comparative trial of isoniazid in combination with thiacetazone or a subtituted diphenylthiourea (SU 1906) or PAS in the treatment of acute pulmonary tuberculosis in East Africans;East African/British Medical Research Council Thiacetazone/Diphenyl-thiourea Investigation;Tubercle,1960
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Systematic review of efficacy and safety of shorter regimens for drug-resistant tuberculosis (DR-TB) in children;Clinical Epidemiology and Global Health;2024-05
2. Effectiveness and safety of Levofloxacin containing regimen in the treatment of Isoniazid mono-resistant pulmonary Tuberculosis: a systematic review;Frontiers in Medicine;2023-06-20
3. Treatment of Isoniazid-Resistant Pulmonary Tuberculosis;Tuberculosis and Respiratory Diseases;2020
4. Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa;The International Journal of Tuberculosis and Lung Disease;2017-06-01
5. Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis;The Lancet Infectious Diseases;2017-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3